Italy-based medical device company Sorin Group has received CE mark approval for its new mitral valve annuloplasty ring, Memo 3D ReChord.
Memo 3D ReChord is the repair device, which was developed to deliver better patient outcomes while facilitating the surgical procedure.
Sorin Group cardiac surgery business unit president Michel Darnaud said: "Memo 3D ReChord is the latest result of our continuous effort to bring innovation to cardiac surgery teams. It represents a great opportunity to advance our presence in the mitral valve repair market.
"It has been engineered to fulfill the growing demand for faster and more reproducible artificial chord replacement. We are committed to setting high standards in design and performance to support patients and cardiac surgeons in the management of mitral valve disease."
Featuring chordal guiding system, the Memo 3D ReChord makes artificial chordae tendineae replacement a routine and standardized procedure.
In addition, the system features Carbofilm coating and laser cut Ni-Ti Ni-Ti technology, which improves physiologic performance.
Sorin develops and markets medical technologies for cardiac surgery, as well as for the treatment of cardiac rhythm disorders.
Image: Memo 3D Rechord annuloplasty ring. Photo: courtesy of Business Wire.